Impilo Pharmaceuticals Private Limited, a active private limited company, was established on 05 January 2015 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232KA2015PTC078093. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.30 M.
It upholds a compliant status. Its leadership includes Sandhya Ashish Shinge (Additional Director), Vijay Mathodu Eshwarappa (Whole-Time Director), Aruna Mallippanahalli Dharmeshappa (Whole-Time Director). Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Shed No. 101, 1St Floor, Ind Esta, Rajajinagar, Bangalore, Karnataka, 560010.
U24232KA2015PTC078093
078093
05 January 2015
₹2.00 M
₹0.30 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Impilo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandhya Ashish Shinge | Additional Director | 02 Aug 2016 | Current |
| Vijay Mathodu Eshwarappa | Whole-Time Director | 05 Jan 2015 | Current |
| Aruna Mallippanahalli Dharmeshappa | Whole-Time Director | 05 Jan 2015 | Current |
| Kannambadi Thammaiah Subramaniam | Managing Director | 05 Jan 2015 | Current |
| Pradeep Tokasandra Siddegowda | Whole-Time Director | 05 Jan 2015 | Current |
| Ravishankar Krishnamurthy | Whole-Time Director | 05 Jan 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Impilo Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 20.36% increase. The company also saw a substantial improvement in profitability, with a 198.18% increase in profit. The company's net worth Soared by an impressive increase of 36.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Impilo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Impilo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Impilo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impilo Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Impilo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
The activity Impilo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore. was completed.
Progress on Sandhya Ashish Shinge was appointed as a Additional Director was appointed as a Additional Director on 02 Aug 2016 & has been associated with this company since 9 years 4 months . was documented.
Progress on Vijay Mathodu Eshwarappa was appointed as a Whole-time director was appointed as a Whole-time director on 05 Jan 2015 & has been associated with this company since 10 years 10 months . was documented.
Progress on Aruna Mallippanahalli Dharmeshappa was appointed as a Whole-time director was appointed as a Whole-time director on 05 Jan 2015 & has been associated with this company since 10 years 10 months . was documented.
The activity Kannambadi Thammaiah Subramaniam was appointed as a Managing Director was appointed as a Managing Director on 05 Jan 2015 & has been associated with this company since 10 years 10 months . was completed.
The CIN of Impilo Pharmaceuticals Private Limited is U24232KA2015PTC078093.
Impilo Pharmaceuticals Private Limited is headquartered at Shed No. 101, 1St Floor, Ind Esta, Rajajinagar, Bangalore, Karnataka, 560010.
Impilo Pharmaceuticals Private Limited was incorporated on 05 January 2015.
The current directors of Impilo Pharmaceuticals Private Limited are
The primary industry of Impilo Pharmaceuticals Private Limited is Trade.
Impilo Pharmaceuticals Private Limited is unlisted.
The authorized capital of Impilo Pharmaceuticals Private Limited is ₹2.00 M, and the paid-up capital is ₹0.30 M.
The compliance status of Impilo Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX